| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193681 | Annals of Allergy, Asthma & Immunology | 2006 | 9 Pages |
Abstract
Even at the higher doses used to treat more severe cases of asthma, ciclesonide was observed to have no effect on HPA axis function. These data, in conjunction with the observed clinical efficacy, suggest that ciclesonide may have an improved therapeutic margin compared with some other currently available inhaled corticosteroid treatments and, therefore, the potential to improve therapeutic outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Eli O. MD, Hartmut PhD,